Most Recent
Aristocrat has fended off the Commissioner of Patents' challenge to a finding that its Lightning Link poker machine is capable of being patented, with the High Court declining to weigh in on the patent for a second time.
Danish company Vestesen Hybrid Energy has taken Zenith Energy to court for allegedly infringing its patented system for operating an electrical grid where energy is generated by a fluctuating renewable energy source.
A judge has rejected Apple's bid for $1 million in security for costs for a patent-holding company's appeal in its failed IP case over the tech company's Touch ID and Face ID technology.
Zoetis has been ordered to pay Scidera’s costs of defending an unsuccessful summary dismissal application on a lump sum basis in a dispute over a bovine gene patent, with a judge rejecting its “premature” bid for a set-off.
The High Court will not hear sports merchandise company Fanatics' trade mark fight with AFL apparel maker FanFirm, which Fanatics argued would provide guidance on the defence of honest concurrent use.
A judge has declined to order US-based animal genomics company Scidera to file a position statement in its bovine gene patent infringement suit and said she was “running out of patience” after unsuccessful strike-out and summary dismissal applications by the defendants.
Acciona is mulling a bid to summarily dismiss a "hopelessly flawed" patent suit by its construction partner on the troubled East Rockingham waste-to-energy plant project, saying it is doomed in light of a High Court decision holding a patentee’s rights are exhausted at the time of sale.
Suspecting infringement of patents for its Parkinson's drug, Xadago, biopharmaceutical company Newron has won preliminary discovery of documents from generic drug maker Arrotex Pharmaceuticals.
The High Court has been asked to clarify the extent to which computer-implemented ideas are eligible for patent protection, with IP Australia appealing a win for gaming giant Aristocrat.
Animal drug company Zoetis has lost its bid for summary dismissal of claims that it infringed US-based animal genomics company Scidera's bovine gene patent, with a judge saying its novel arguments were not so clear-cut and needed to be worked out at trial.